A new vaginal probiotic has been launched, targeting the health of the vaginal microbiome and promising benefits such as reduced infections and improved hormonal balance. With a projected revenue increase to $200 million in 2024, the company boasts a patented capsule that effectively delivers live bacteria without the need for refrigeration. This innovative approach positions them as leaders in a rapidly growing market.
